European Companies Search Engine
Registration · CxO: Hans Karl Herr · Address · Capital: €50,000 · Seat: Berlin · Legal form: AG · Name: New Medical Enzymes AG Research & Development · Proxy policy · Company statute … Hrb10 Sept 2009 German Trade Register Announcements, Germany (08/09/2009)
Overview
Text
New Medical Enzymes AG Research & Development,
Unnamed street ??, 10719 Berlin, Germany
. Company: New Medical Enzymes AG Research & Development; Registered office/branch: Berlin; Business address:
Unnamed street ??, 10719 Berlin, Germany
; Subject: Research, manufacture and distribution of products as well as the exploitation of intellectual property rights in enzyme and other pharmaceutical sectors, insofar as no activities subject to authorisation are affected under Section 13 of the German Medicines Act (AMG). Share capital: EUR 50,000.00; Representation regulation: If a member of the Board of Management is appointed, the company alone represents it. If several members of the Board of Management have been appointed, the Company shall be represented by two members of the Board of Management or by a member of the Board of Management in association with an authorized representative. The Supervisory Board of the Company may grant individual members of the Management Board the right to represent them alone. Board of Directors: 1 Herr, Hans Karl, *??.??.????, Berlin; with the power to represent the company alone with the power to enter into legal transactions as a representative of third parties; Legal form: AG; Articles of Association of: August 6, 2009.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: New Medical Enzymes GmbH, Berlin, Germany.